David Capital Partners, LLC 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 3:24 pm Purchase |
2024-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
David Capital Partners, LLC | 1,803,000 4.870% |
1,803,000 (New Position) |
Filing |
| 2024-11-12 5:55 pm Purchase |
2024-09-30 | 13G | Lifecore Biomedical, Inc. LFCR |
David Capital Partners, LLC | 1,655,000 5.360% |
1,655,000 (New Position) |
Filing |